Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".

ABSTRACT:

SUBMITTER: Belonje AM 

PROVIDER: S-EPMC2243255 | biostudies-literature | 2008 Feb

REPOSITORIES: biostudies-literature